Home › Chronic Myelomonocytic Leukemia › Oregon › Portland
Chronic Myelomonocytic Leukemia clinical trials in Portland, OR
3 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
- Oregon Health and Science University, Portland
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- Oregon Health & Science University, Portland
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
RecruitingPhase 1
- OHSU, Portland
Chronic Myelomonocytic Leukemia trials in other cities
- Houston, TX16 studies
- Seattle, WA10 studies
- Boston, MA7 studies
- Mountain View, CA6 studies
- Baldwin Park, CA6 studies
- Rochester, MN6 studies
- New York City, NY6 studies
- Durham, NC5 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Birmingham, AL4 studies
- Columbus, OH4 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.